echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimer's & Dementia: Relationship between plasma NfL and dementia: HABLE study results

    Alzheimer's & Dementia: Relationship between plasma NfL and dementia: HABLE study results

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Although cerebrospinal fluid (CSF) and positron emission tomography (PET) biomarkers may become the ultimate diagnostic tool for the detection of Alzheimer’s disease (AD) , we still urgently need a cost-effective, non-invasive, multi-level Methods to determine who should and should not undergo these expensive and more invasive tests
    .

    diagnosis

    Recently, researchers have proposed that a multi-level neurodiagnostic process can meet these needs, and there is already evidence that blood-based biomarker profiles can be used to detect AD, mild cognitive impairment (MCI), Parkinson’s disease, and Lewis An accurate first step in dementia and AD and MCI in adults with Down syndrome
    .

    As the diagnostic framework of AD shifts to AT (N), in addition to amyloid β (A) and tau (T), more and more work has begun to focus on the utility of neurodegenerative biomarkers (N)
    .


    In recent years, a more interesting neurodegenerative biomarker is neurofilament light chain (NfL), which is a cytoskeletal protein expressed in large-caliber myelinated axons and can be released as a result of axonal injury Extracellular fluid


    Although NfL can be detected throughout the lifespan, many studies have shown that the increase in NfL levels is related to the diagnostic status of AD, and it has received great attention as a potential biomarker of AD
    .


    A recent meta-analysis found that there is a good correlation between blood and cerebrospinal fluid NfL levels (r = 0.


    There is a good correlation between NfL levels in blood and cerebrospinal fluid.


    Changes in plasma NfL are also related to changes in overall cognition, attention and amyloid PET levels


    NfLl level of medical co-morbidity index by race

    NfLl level of medical co-morbidity index by race NfLl level of medical co-morbidity index by race

    In the unadjusted model, NfL was significantly associated with age (P <.
    001), hypertension (P <.
    001), dyslipidemia (P = .
    02), and diabetes (P <.
    001)
    .


    In the subset with data, considering age and gender, NfL is related to neurodegeneration (P <.


    NfL is significantly related to age (P <.


     

    Original source:

    Original source:

    Sid O'Bryant et al.


    Sid O'Bryant et al.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.